title: Doxazosin treatment of phaeochromocytoma during pregnancy: placental transfer and disposition in breast milk.
authors.affiliation: Department of Internal Medicine.
authors.forename: Jorie
authors.identifier: 0000-0003-0674-7765
authors.initials: J
authors.lastname: Versmissen
authors.affiliation: Department of Hospital Pharmacy.
authors.forename: Birgit C P
authors.initials: BC
authors.lastname: Koch
authors.affiliation: Department of Pediatrics, Division of Neonatology and.
authors.forename: Daniëlla W E
authors.initials: DW
authors.lastname: Roofthooft
authors.affiliation: Department of Hospital Pharmacy.
authors.forename: Willemijn
authors.initials: W
authors.lastname: Ten Bosch-Dijksman
authors.affiliation: Department of Internal Medicine.
authors.forename: Anton H
authors.initials: AH
authors.lastname: van den Meiracker
authors.affiliation: Department of Hospital Pharmacy.
authors.forename: Lidwien M
authors.initials: LM
authors.lastname: Hanff
authors.affiliation: Department of Internal Medicine.|Department of Obstetrics and Gynaecology, Division of Obstetrics and Prenatal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
authors.forename: Willy
authors.initials: W
authors.lastname: Visser
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000188:drug therapy*; D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D000328:Adult; D017292:Doxazosin / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008431:Maternal-Fetal Exchange; D008895:Milk, Human / Q000737:chemistry / Q000378:metabolism*; D010673:Pheochromocytoma / Q000188:drug therapy*; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*
chemical_list: D000317:Adrenergic alpha-Antagonists; D017292:Doxazosin